<![CDATA[Shilpa Medicare Ltd 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=51125>Wed, 08 Jul 2026 02:25:35 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe]]>https://www.newswire.co.kr/newsRead.php?no=1038065Tue, 07 Jul 2026 11:20:00 +0900<![CDATA[오리온-실파 메디케어, 유럽 시장용 니볼루맙 바이오시밀러 개발·공급 위한 파트너십 확대]]>https://www.newswire.co.kr/newsRead.php?no=1038066Tue, 07 Jul 2026 11:20:00 +0900<![CDATA[Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy]]>https://www.newswire.co.kr/newsRead.php?no=1036217Wed, 10 Jun 2026 14:00:00 +0900<![CDATA[실파 메디케어-게이트2브레인, 최초의 뇌암 치료제 개발 위한 전략적 지분 파트너십 체결]]>https://www.newswire.co.kr/newsRead.php?no=1036219Wed, 10 Jun 2026 14:00:00 +0900